These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32007389)

  • 1. Very Prolonged Anti-D: Confusion Surrounding Alloimmunization After Extra Rh Immunoglobulin: A Case Report.
    Karol DL; Shehata N; Selk A
    J Obstet Gynaecol Can; 2020 Sep; 42(9):1151-1153. PubMed ID: 32007389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
    Aitken SL; Tichy EM
    Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline No. 448: Prevention of Rh D Alloimmunization.
    Fung-Kee-Fung K; Wong K; Walsh J; Hamel C; Clarke G
    J Obstet Gynaecol Can; 2024 Apr; 46(4):102449. PubMed ID: 38553007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of Rh D alloimmunization in the first trimester of the pregnancy: French College of Obstetricians and Gynecologists guidelines for clinical practice].
    Vigoureux S; Maurice P; Sibiude J; Garabedian C; Sananès N
    Gynecol Obstet Fertil Senol; 2024; 52(7-8):446-453. PubMed ID: 38417789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhesus Negative Woman Transfused With Rhesus Positive Blood: Subsequent Normal Pregnancy Without Anti D production.
    Maya ET; Buntugu KA; Pobee F; Srofenyoh EK
    Ghana Med J; 2015 Mar; 49(1):60-3. PubMed ID: 26339087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant].
    L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M
    Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New laboratory procedures and Rh blood type changes in a pregnant woman.
    Sandler SG; Li W; Langeberg A; Landy HJ
    Obstet Gynecol; 2012 Feb; 119(2 Pt 2):426-428. PubMed ID: 22270426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD).
    Anderson B; Shad AT; Gootenberg JE; Sandler SG
    Am J Hematol; 1999 Mar; 60(3):245-7. PubMed ID: 10072121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
    Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
    Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inaccurate doses of R immune globulin after rh-incompatible fetomaternal hemorrhage: survey of laboratory practice.
    Ramsey G;
    Arch Pathol Lab Med; 2009 Mar; 133(3):465-9. PubMed ID: 19260751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy <12 weeks gestation.
    Horvath S; Wang L; Calo W; Yazer MH
    Contraception; 2024 Nov; 139():110530. PubMed ID: 38906503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis.
    Szkotak AJ; Lunty B; Nahirniak S; Clarke G
    Vox Sang; 2016 Jan; 110(1):51-9. PubMed ID: 26031621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 15. Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.
    Obstet Gynecol; 2017 Aug; 130(2):e57-e70. PubMed ID: 28742673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice Bulletin No. 181 Summary: Prevention of Rh D Alloimmunization.
    Obstet Gynecol; 2017 Aug; 130(2):481-483. PubMed ID: 28742667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin.
    Rushin J; Rumsey DH; Ewing CA; Sandler SG
    Transfusion; 2000 May; 40(5):551-4. PubMed ID: 10827257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rh immune globulin: an interfering substance in compatibility testing.
    Casina TS; Sandler SG; Autenrieth SM
    Immunohematology; 2019 Jun; 35(2):51-60. PubMed ID: 31246488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.